SR9009 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-10. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
=== Strategies for NMR analysis === The two basic methods of NMR analysis are single- and double-derivatization. Double-derivatization is generally considered more accurate, but single-derivatization usually requires less reagents and, thus, is more cost effective.
=== Vitamin B12 === Spirulina contains no vitamin B12 naturally, and spirulina supplements are not considered a reliable source of vitamin B12, as they contain predominantly pseudovitamin B12 (Coα-[α-(7-adenyl)]-Coβ-cyanocobamide), which is biologically inactive in humans. In a 2009 position paper on vegetarian diets, the American Dietetic Association stated that spirulina is not a reliable source of active vitamin B12. The medical literature similarly advises that spirulina is unsuitable as a source of B12.
An estimated 3.9 million tonnes (t) of nickel per year are mined worldwide; Indonesia (2,600,000 t), the Philippines (270,000 t), Russia (200,000 t), Canada (140,000 t), New Caledonia (140,000 t), and China (120,000 t) are the largest producers as of 2025. The largest nickel deposits in non-Russian Europe are in Finland and Greece. Identified land-based sources averaging at least 1% nickel contain at least 130 million tonnes of nickel. About 60% is in laterites and 40% is in sulfide deposits. Also, extensive nickel sources are found in the depths of the Pacific Ocean, especially in an area called the Clarion Clipperton Zone in the form of polymetallic nodules peppering the seafloor at 3.5–6 km below sea level. These nodules are composed of numerous rare-earth metals and are estimated to be 1.7% nickel. With advances in science and engineering, regulation is currently being set in place by the International Seabed Authority to ensure that these nodules are collected in an environmentally conscientious manner while adhering to the United Nations Sustainable Development Goals. The one place in the United States where nickel has been profitably mined is Riddle, Oregon, with several square miles of nickel-bearing garnierite surface deposits. The mine closed in 1987. The Eagle mine project is a new nickel mine in Michigan's Upper Peninsula. Construction was completed in 2013, and operations began in the third quarter of 2014. In the first full year of operation, the Eagle Mine produced 18,000 t. The Eagle mine produced 17,000 tons of nickel concentrate in 2023.
Sources: en.wikipedia.org
=== Rosenberg === Dr. Rosenberg (voiced by Jon St. John) is a scientist and a survivor of the Black Mesa incident. He first appears in Half-Life: Decay. When Gina Cross and Colette Green first arrive at the test chamber's control room and are receiving instructions from Dr. Keller, Rosenberg interrupts and voices his concern to Keller over having the anti-mass spectrometer run above 90% capacity, which is past the safety buffer zone for the equipment. Dr. Keller, however, dismisses his concern and states that the administrator's orders for this were clear. He tells Rosenberg that he can either stay and watch the experiment or return to his labs by the train yards. Rosenberg remains, and shortly thereafter the Resonance Cascade occurs. Immediately after the disaster, Rosenberg converses with Dr. Keller and makes it clear that he believes their greatest responsibility should be the safety of the people at Black Mesa. Although Keller thinks that they should attempt to reset the displacement fields first, he eventually agrees with Rosenberg, and they come up with a plan to contact the military, so that they can help and evacuate the facility as soon as possible. Gina and Colette escort Rosenberg through the Hazard Course to a satellite communications center on the surface, where he is able to transmit a distress signal. Dr. Rosenberg decides to wait there for the military, and this is the last time he is seen in Decay as Gina and Colette return below to assist Dr. Keller. However, his voice is heard once more in the game later on.
=== Hydrogen isotope formation === 1H, with one proton and no neutrons, is the most abundant nuclide in the Solar System, formed in the earliest rounds of stellar explosions after the Big Bang. After the universe exploded into life, the hot and dense cloud of particles began to cool, first forming subatomic particles like quarks and electrons, which then condensed to form protons and neutrons. Elements larger than hydrogen and helium were produced with successive stars, forming from the energy released during supernovae. Deuterium, 2H, with one proton and one neutron, is also known to have cosmic origin. Like protium, deuterium was produced very early in the universe's history, during Big Bang nucleosynthesis (BBN). As protons and neutrons combined, helium-4 was produced with a deuterium intermediate. Alpha reactions with 4He produce many of the larger elements that dominate today's Solar System. However, before the universe cooled, high-energy photons destroyed any deuterium, preventing larger element formation. This is called the deuterium bottleneck, a restriction on the timeline for nucleosynthesis. All of today's deuterium originated from this proton-proton fusion after enough cooling. Tritium, 3H, with one proton and two neutrons, was produced by proton and neutron collisions in the early universe as well, but it has since radioactively decayed to helium-3. Today's tritium cannot be from BBN, due to tritium's short half-life, 12.3 years. Today's 3H concentration is instead governed by nuclear reactions and cosmic rays.
On 19 March 2015, a group of leading biologists urged a worldwide ban on clinical use of methods, particularly the use of CRISPR and zinc finger, to edit the human genome in a way that can be inherited. In April 2015, Chinese researchers reported results of basic research to edit the DNA of non-viable human embryos using CRISPR.
When danger loomed, all the burgers (citizens) in a district would form a military unit called a commando and elect officers. A full-time official called a Veldkornet maintained muster rolls but had no disciplinary powers. Each man brought his own weapon, usually a hunting rifle, and horse. Those who could not afford a gun were given one by the authorities. The presidents of the Transvaal and Orange Free State simply signed decrees to concentrate within a week, and the commandos could muster between 30,000-40,000 men. Many did not look forward to fighting against fellow Christians and, by and large, fellow Protestants. Many had an overly optimistic sense of what the war would involve, imagining victory could be achieved as fast and easily as in the First Anglo-Boer War. Many, including many generals, had a sense their cause was holy and just, and blessed by God. It rapidly became clear that the Boers presented the British forces with a severe tactical challenge. The Boers presented a mobile and innovative approach to warfare, drawing on their experiences from the First Boer War. The Boers who made up their commandos were farmers who had their working life in the saddle, as farmers and hunters. They depended on the pot, horse and rifle; they were skilled stalkers and marksmen. As hunters, they had learned to fire from cover; from a prone position and to make the first shot count, knowing that if they missed, the game would be long gone or could charge and potentially kill them.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.